|
|
Post by orlon on Oct 2, 2016 20:34:47 GMT -5
"Betty and Eddy are Tresiba ready. Ask your doctor if Tresiba is for you....". More and more of these drugs are hitting the market via airways. Where is AFREZZA? 70 reps in a population of 323,000,000 (thanks for pointing out my exuberance of adding three more zeros😄.) Afrezza is not going to reach a few million diabetics by a few ads in magazines, compared to those on tv such as Tresiba. Worried about restrictions and side effects? Listen to any tv ad...they are mentioned. Personally I don't have 10-20 years to see if AFREZZA becomes a blockbuster...I think many who have been invested in this company for years on this board feel the same.
|
|
|
|
Tresiba
Oct 2, 2016 20:36:04 GMT -5
via mobile
Post by dictatorsaurus on Oct 2, 2016 20:36:04 GMT -5
They are too broke buddy. Not enough Mola for TV ads.
|
|
Deleted
Deleted Member
Posts: 0
|
Tresiba
Oct 2, 2016 22:35:01 GMT -5
Post by Deleted on Oct 2, 2016 22:35:01 GMT -5
"Betty and Eddy are Tresiba ready. Ask your doctor if Tresiba is for you....". More and more of these drugs are hitting the market via airways. Where is AFREZZA? 70 reps in a population of 323,000,000 (thanks for pointing out my exuberance of adding three more zeros😄.) Afrezza is not going to reach a few million diabetics by a few ads in magazines, compared to those on tv such as Tresiba. Worried about restrictions and side effects? Listen to any tv ad...they are mentioned. Personally I don't have 10-20 years to see if AFREZZA becomes a blockbuster...I think many who have been invested in this company for years on this board feel the same. Here is my opinion: TV infomercials are manipulating and are no different than any other form of advertisement that companies spend mucho grande on because there is an actual science behind persuading people. MannKind, I hope, will not do that. There is a right way and a corrupt way. TV interviews—fine and I agree with. Tresiba's TV ad looks like a joke. Actually, looks like all the other pharma TV ads. Fake people, fake, fake, fake. Some things do not need to be advertized in a "professional infomercial" with paid actors. Afrezza speaks for itself. I am allfor real interviews with real users, but good god, I hope MannKind does not stoop to the level of greedy pharma. |
|
|
|
Post by liane on Oct 3, 2016 4:21:09 GMT -5
"Tresiba ready" is one of those jingles I can't get out of my head (in a bad, not a good way).
|
|
|
|
Post by nimrod71 on Oct 3, 2016 4:37:00 GMT -5
I hope they do stoop to the level of greedy Pharma. The corrupt way? Unbelievable! Mnkd is breathing it's last breaths and this is what concerns you.
|
|
|
|
Tresiba
Oct 3, 2016 22:53:56 GMT -5
Post by sweedee79 on Oct 3, 2016 22:53:56 GMT -5
"Betty and Eddy are Tresiba ready. Ask your doctor if Tresiba is for you....". More and more of these drugs are hitting the market via airways. Where is AFREZZA? 70 reps in a population of 323,000,000 (thanks for pointing out my exuberance of adding three more zeros😄.) Afrezza is not going to reach a few million diabetics by a few ads in magazines, compared to those on tv such as Tresiba. Worried about restrictions and side effects? Listen to any tv ad...they are mentioned. Personally I don't have 10-20 years to see if AFREZZA becomes a blockbuster...I think many who have been invested in this company for years on this board feel the same. "Betty and Eddy are Tresiba ready. Ask your doctor if Tresiba is for you....". LOL ... that is hilarious.. I don't watch tv .. so I haven't heard this one.. I can see how that would stick in your brain... and honestly that is smart ..
Tresiba is a different marketing story than Afrezza .. Tresiba by comparison is better than lantus.. but not that much different.. not a lot of prep work for the company and reps.. and that isn't an excuse, its just the truth..
I trust that MNKD didn't spend all of this money on reps and the ad agency etc etc becuz they have no plans to advertise.. and I will bet that Outsulin is way cuter than Betty and Eddy .. JMHO
We aren't even out with the new packaging yet..... and trust me, the old packaging sucks and makes it confusing to prescribe..
|
|
|
|
Post by careful2invest on Oct 4, 2016 0:35:17 GMT -5
A commercial for AFREZZA?
What a novel idea...
When Sanofi partnered with MNKD, and there were no commercials, everyone was coming up with various scenarios on several message boards, basically guessing as to why. Because the silence did not add up!
Yet no one had ever even heard of AFREZZA.
Speculation went on and on, excuses were made by many trying to rationalize just why there were no advertisements for this revolutionary treatment of Diabetes.
Reluctantly, I too, would accept the reasons (excuses) as to why there were no ads. "It was not time" or one thing or another had to happen first, and then the advertising would begin. And it never happened.
Then finally, we realized that Sanofi was sandbagging.
But it was often said or at least thought that once MNKD gets the rights to AFREZZA back, they can certainly promote it like it should have been promoted all along! And we longs could hardly wait...right?
And here we are again! Or should I say still...
Even now, very few people have even heard of AFREZZA!
Granted, Mike C has done a lot in a relatively short time and I realize that word is getting out, but ever so slowly!
The reason for my post is that it all seems too familiar...
The speculation and the "reasons" that there are no commercials, and very few ads at all
is sounding very similar as when Sanofi held the reigns. Again, It does not seem to add up!
Are we just not privy to what is actually going on behind the scenes?
Otherwise it does not make sense to not have an all out promotion of this ground breaking, revolutionary treatment of Diabetes.
At least to get people to talk about it, or to have at the very minimum, have heard the name AFREZZA.
It just seems that we should be much further along with marketing and exposure of AFREZZA, given its revolutionary potential.
Frustrating! Yes!
That said, I'm still not selling!
GLTA TRUE LONGS!
|
|
|
|
Post by agedhippie on Oct 4, 2016 6:25:09 GMT -5
The reason for my post is that it all seems too familiar... The speculation and the "reasons" that there are no commercials, and very few ads at all is sounding very similar as when Sanofi held the reigns. Again, It does not seem to add up! The reason is simple. Insulin is not a revolutionary treatment for diabetes so you have to sell the medical world on it being a better way. You can do DTC advertising now but all that happens is that the doctor looks at the label, sees it performs the same as the RAA and has a black box warning, and goes with RAA. All your wonderful DTC advertising achieves nothing. You have to either have trial data supporting the fact or educate the market doctor by doctor. Right now it's the latter and that takes time. Prescribing insulin is not like prescribing most drugs, if you get insulin wrong the patient can die really fast (incidentally why my PCP will not prescribe insulin at all but refers you to an endo). Doctors are far more nervous about getting that sort of decision wrong for obvious reasons so they are conservative in their approach. |
|
|
|
Post by LosingMyBullishness on Oct 4, 2016 7:14:54 GMT -5
IMO we try to achieve too much with an DTC by aiming for the perfect timing (that might be very much in the future).
We wait for MNKDs request for a label change (something that was in its final review at Matt's desk just before his last public speech and I have not seen any PR that it was submitted. Has someone tracked this?) and a positive decision by the FDA, we wait for insurance and a critical mass of endos..
But wouldn't it be sufficient right now if we get AWARENESS and at least some excitement.
Sure there is a black box warning, but honestly,'Do not use AFREZZA if you have long-term (chronic) lung problems such as asthma or chronic obstructive pulmonary disease (COPD)' should not be a issue for enough diabetics to get us to cash-even and beyond.
IMO this black box warning is very much exagerated by some folks, as if 80% of the diabetics have asthma or COPD. How much % of the US diabetics market do we need for break even? 5%?
Besides: I think Mannmade posted a link to drugs that have hugh sideeffects but are immensely popular in the US (PROZAC and such).
Again: If the DTC creates awareness it is good enough. It is one essential piece in the puzzle.
|
|
|
|
Post by agedhippie on Oct 4, 2016 7:49:49 GMT -5
Again: If the DTC creates awareness it is good enough. It is one essential piece in the puzzle. Generally this is true but it presupposes we have sufficient funds to engage in marketing where there is no immediate return. Right now it feels like Mike is picking low cost highly targeted events that are likely to generate that return more immediately. |
|
|
|
Post by LosingMyBullishness on Oct 4, 2016 8:03:55 GMT -5
Again: If the DTC creates awareness it is good enough. It is one essential piece in the puzzle. Generally this is true but it presupposes we have sufficient funds to engage in marketing where there is no immediate return. Right now it feels like Mike is picking low cost highly targeted events that are likely to generate that return more immediately. Well, there could be an immediate return: It creates uncertainty and fear with shorts which have been the main sellers lately and some would cover. Plus there would be some new investors getting aware of the company MNKD as a speculative buy. This together would increase the share price and MNKD would get a better price if (and this is a IF) they need to sell more shares. EDIT: I am not against the grassroot campaign and the campaign in medical publications. This is fine. But what would you do if you have to anticipate that it takes another 6-12 month to get the awareness you need to generate more script numbers? I understand that such a campaign could spoil the target audience but everything in life comes with risks. |
|
|
|
Tresiba
Oct 4, 2016 8:48:02 GMT -5
via mobile
Post by straightly on Oct 4, 2016 8:48:02 GMT -5
IMO we try to achieve too much with an DTC by aiming for the perfect timing (that might be very much in the future). We wait for MNKDs request for a label change (something that was in its final review at Matt's desk just before his last public speech and I have not seen any PR that it was submitted. Has someone tracked this?) and a positive decision by the FDA, we wait for insurance and a critical mass of endos.. But wouldn't it be sufficient right now if we get AWARENESS and at least some excitement. Sure there is a black box warning, but honestly,'Do not use AFREZZA if you have long-term (chronic) lung problems such as asthma or chronic obstructive pulmonary disease (COPD)' should not be a issue for enough diabetics to get us to cash-even and beyond. IMO this black box warning is very much exagerated by some folks, as if 80% of the diabetics have asthma or COPD. How much % of the US diabetics market do we need for break even? 5%? Besides: I think Mannmade posted a link to drugs that have hugh sideeffects but are immensely popular in the US (PROZAC and such). Again: If the DTC creates awareness it is good enough. It is one essential piece in the puzzle. Is it just me: reading M. C twitters, I got a feeling that there were something holding him back aside from money. I believe it is a mistake to believe any one DTC would work: we have to try many. |
|
|
|
Post by peppy on Oct 4, 2016 9:04:24 GMT -5
" Betty and Eddy are Tresiba ready. Ask your doctor if Tresiba is for you....". More and more of these drugs are hitting the market via airways. Where is AFREZZA? 70 reps in a population of 323,000,000 (thanks for pointing out my exuberance of adding three more zeros😄.) Afrezza is not going to reach a few million diabetics by a few ads in magazines, compared to those on tv such as Tresiba. Worried about restrictions and side effects? Listen to any tv ad...they are mentioned. Personally I don't have 10-20 years to see if AFREZZA becomes a blockbuster...I think many who have been invested in this company for years on this board feel the same. Quote: Betty and Eddy are Tresiba ready. Tresiba a basal insulin.
The Ada guidelines read, mealtime insulin is started after basal screencast.com/t/nOwBa4aaA
Seen differently, "Betty and Eddy are Tresiba ready'" is the afrezza preamble.
Novo is marketing Tresiba. Revenues in the billions of dollars. www.novo-pi.com/tresiba.pdf
(It is theorized by me, that with afrezza, some type two's would not need basal. Continuous glucose monitors could say for sure.)
|
|
